logo
Best stocks: This software name is a category killer and has broken out

Best stocks: This software name is a category killer and has broken out

CNBC15-05-2025

(This is The Best Stocks in the Market , brought to you by Josh Brown and Sean Russo of Ritholtz Wealth Management.) Josh: Today we're spotlighting a stock you've probably heard me talking about on CNBC over the past few years, Toast (TOST) . For the first time ever, Toast has hit our list of the Best Stocks in the Market . Sean was really excited to write this one up and I was excited to read his take on the fundamental story. My take is very simple — I believe this company has reached the point where it is an established, acknowledged category killer. I love catching stories like these in the earlier stages, before everyone figures out the dominant player is going to have advantages that become cumulative. This is where the Toast story is now. The more penetration they get into a given metropolitan area, the more local service industry workers (and their employers) are comfortable using the software within their counter service or restaurant business. Toast becomes the de facto default option for point-of-sale payment systems. Everyone is trained on it and it becomes entrenched. Once Toast gets to a certain threshold within these markets, it's a wrap. They are then able to knock down the rest of local players and the sales cycle gets shorter and easier. Next they can sell all sorts of horizontal software solutions to the same population of customers — food ordering, staff tracking, payroll, etc. Writing about the company's most recent quarterly report last week, Mizuho analyst Dan Dolev cited the company's ability to defy the "difficult environment" for restaurants and relay strong guidance while giants McDonalds, Sweetgreen and Chipotle were posting warnings. Dan was bullish about Toast's increased take rate as well — they kept 48 basis points of all transaction revenue on their platform (1 basis point equals 0.01%). He sees even more opportunity on this front as contracts with customer-restaurants are renegotiated. I originally put this position on for myself as a trade a long time ago but the more I saw these guys execute, the more I wanted to stay. Now I consider myself a long-term investor in the name. Best Stock Spotlight: Toast Inc (TOST) On the list since: May 13th, 2025 Sean: TOST is a digital platform for 140,000-plus restaurants, generating revenue from subscription fees and transaction fees. Unlike its competitors, Toast intermediates every payment transaction on its platform; it processed more than $150 billion in gross platform volume in 2024. TOST is digitizing the fragmented and highly competitive restaurant industry, and the stock is breaking out. TOST just broke out above its November 2024 high of $43. TOST hasn't traded above the $45 mark since November of 2021. Similar to Monday's Best Stocks in the Market piece on Carvana, TOST has spent a lot of time below all time highs. TOST has been a public company since September of 2021, equal to 916 trading days. Of those 916 trading days, TOST saw an all time high on just 3 of them, and the first 2 all-time highs came on the first and second day of trading. It's last all time high occurred on November 3rd of 2021 — 885 days ago. TOST's all-time low came in May of 2022 in the midst of the hottest run of inflation prints the market had seen since the early 80s. Investors priced in a reduction of restaurant spending by consumers because of this inflation. A recession became the base case for nearly 100% of economists. Those economists were wrong, and we saw the hottest spending trends come into the service category. In 2023, consumer spending on food away from home increased to $1.5 trillion, up from $1.3 trillion in 2022, marking a significant shift as dining out expenditures surpassed grocery spending. TOST is up 254% off its 2022 low. TOST hit $43 in November as the animal spirits about the U.S. economy came roaring into the headlines. From that November level, TOST hit a low of $30 on April 8th, down 30% from November, again reflecting worries about the U.S. consumer and their ability to spend with an ongoing trade war. Again, we're seeing economists throw the recession word around. And again, TOST is shrugging off those worries. High-growth stock TOST is a high-growth business. It has compounded its top line revenue by 48% annually going back to 2020. Their profitability is growing too. Looking at its operating margin from Q4 of 2023 through Q1 of 2025, its gone from -4.1% to 3.7%, growing profitability by 780 basis points. Part of the reason why TOST landed on our list is the outstanding earnings call it just reported. TOST delivered record Q1 2025 results with 31% annual recurring revenue growth, 22% gross payment volume growth, and profitability driven by strong customer spending and massive enterprise wins. TOST added 6,000 net new locations bringing the total to 140,000 locations, which is a 25% YoY increase. Toast's profitability margins have improved significantly. Gross profit margin increased from 20.5% in Q4 2022 to 25.9% in Q1 2025. Operating margin turned positive, going from -12.9% to 3.2%. Net profit margins improved from -12.9% to 4.19%, and EBITDA margin grew from -12.1% to 10.0% over the same period. (data via QUARTR) TOST also reported a partnership with Applebee's, which represents the company's largest deal to date. The enterprise pipeline is described as the strongest it has ever been for TOST, with ongoing conversations with other large brands. The economics of these enterprise deals are super beneficial for TOST, with large value-add ARR opportunities and lower churn rates for larger customers. TOST reported these numbers on May 8, and the stock was up 11.4% the next day. From April 8th through 5/14 the stock is up 50%. The market is pricing in this growth, and the stock is in breakout mode. Risk Management Josh: My instinct here is the stock pulls back and retests the recent breakout. If the volume is light and the buyers come in to defend that gap ($39.75), that becomes the new support and we could be off to the races. If Toast gets back into the gap and fills it, you're back in the $35-$37 range, coincidentally the rising 200-day is there to cushion the fall as well (see below). Toast has been a volatile stock as investors doubted the company's commitment to reaching consistent profitability. Now those doubts are fading away and my hope would be that the volatility can fade with them. DISCLOSURES: Josh owns the stock All opinions expressed by the CNBC Pro contributors are solely their opinions and do not reflect the opinions of CNBC, NBC UNIVERSAL, their parent company or affiliates, and may have been previously disseminated by them on television, radio, internet or another medium. THE ABOVE CONTENT IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY . THIS CONTENT IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSITUTE FINANCIAL, INVESTMENT, TAX OR LEGAL ADVICE OR A RECOMMENDATION TO BUY ANY SECURITY OR OTHER FINANCIAL ASSET. THE CONTENT IS GENERAL IN NATURE AND DOES NOT REFLECT ANY INDIVIDUAL'S UNIQUE PERSONAL CIRCUMSTANCES. THE ABOVE CONTENT MIGHT NOT BE SUITABLE FOR YOUR PARTICULAR CIRCUMSTANCES. BEFORE MAKING ANY FINANCIAL DECISIONS, YOU SHOULD STRONGLY CONSIDER SEEKING ADVICE FROM YOUR OWN FINANCIAL OR INVESTMENT ADVISOR. INVESTING INVOLVES RISK. EXAMPLES OF ANALYSIS CONTAINED IN THIS ARTICLE ARE ONLY EXAMPLES. THE VIEWS AND OPINIONS EXPRESSED ARE THOSE OF THE CONTRIBUTORS AND DO NOT NECESSARILY REFLECT THE OFFICIAL POLICY OR POSITION OF RITHOLTZ WEALTH MANAGEMENT, LLC. JOSH BROWN IS THE CEO OF RITHOLTZ WEALTH MANAGEMENT AND MAY MAINTAIN A SECURITY POSITION IN THE SECURITIES DISCUSSED. ASSUMPTIONS MADE WITHIN THE ANALYSIS ARE NOT REFLECTIVE OF THE POSITION OF RITHOLTZ WEALTH MANAGEMENT, LLC" TO THE END OF OR OUR DISCLOSURE. Click here for the full disclaimer.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Best Stocks: Three healthcare names to ponder including a biotech back to levels not seen in a decade
Best Stocks: Three healthcare names to ponder including a biotech back to levels not seen in a decade

CNBC

timea day ago

  • CNBC

Best Stocks: Three healthcare names to ponder including a biotech back to levels not seen in a decade

(This is The Best Stocks in the Market , brought to you by Josh Brown and Sean Russo of Ritholtz Wealth Management.) Josh here — The healthcare sector has entered the chat. There are 12 healthcare names now on our Best Stocks list as of the end of last week. I'll show you a few of these set-ups below and then Sean's going to share some fundamentals for these healthcare firms. Sector Leaderboard As of 6/9/2025 morning, there are 114 names on The Best Stocks in the Market list Top Sector Ranking: Top Industries: Top 5 Best Stocks by Relative Strength: Sector Spotlight: Healthcare Josh — Alnylam Pharma (ALNY) just broke out above prior resistance at $300. There was company-specific news about new indications for one of their most important drugs that led to multiple price target raises on The Street. Alnylam is named for Alnilam, the brightest star in the Belt of Orion constellation, which ancient mariners used for navigation. The founders of the company believed their trailblazing work in the field of RNA interference (RNAi) would chart a brand new course of drug discovery and development by which the next generation of scientists would be guided. So far, so good as ALNY grew revenue to $2.25 billion in revenue last year and the company's market cap swelled to a respectable $40 billion. Wall Street's median price target is ten percent higher than today's price while the most bullish analyst, H.C. Wainwright, just published a target of $500 this past week. In Q1 2025, revenue surged by over 28% year-over-year to approximately $594 million, driven largely by the strength of the TTR franchise. Looking ahead, analysts project revenue growth of 24–33% through 2025–2026, supported by improving EPS and an expected annual revenue of $2.9 billion. The company also maintains a strong balance sheet, with around $223 million in free cash flow, a quick ratio of approximately 2.7×, and increasing support from major institutional investors who are adding to their positions. (data via Reuters) Sean — AMVUTTRA (vutrisiran) was recently FDA‑approved for cardiomyopathy, expanding its market from neuropathy, which is a major catalyst for the stock — it significantly expands its addressable market beyond its original use for polyneuropathy. This approval allows Alnylam to target patients with transthyretin amyloid cardiomyopathy (ATTR-CM), a much larger population than those with ATTR polyneuropathy. The drug's unique RNA interference mechanism and dosing schedule (quarterly or biannual injections) give it a competitive edge over existing therapies like Pfizer's Vyndaqel. This dual-indication approval not only boosts Alnylam's revenue potential but also strengthens its path toward profitability, making AMVUTTRA a key growth driver for the company and a pivotal reason for recent momentum. Josh — Allow for short-term consolidation in the $300 area, await the next catalyst. 50-day crossing over 200-day important signal that a new uptrend could be forming. Cardinal Health Josh — All three major Pharmaceutical Wholesalers made the list - McKesson (MCK) , Cencora (COR) and Cardinal Health (CAH) , only Cardinal looks good technically right now: CAH held its 50-day on a weekly closing basis during the April bloodbath, I'd use that area as a stop and update it each week. If the uptrend breaks, there's no reason to be long. Sean — CAH is a $37 billion wholesaler, sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies, hospitals, and healthcare providers. All three names on our list, Cardinal, Cencora, and McKesson, hold well over 90% of the US pharmaceutical wholesale industry. CAH trades at an 18x forward PE and a 15x P/FCF - this thing is generating cash for investors. It has a 1.3% dividend yield and is growing earnings 8% this year, and is expected to grow its earnings 12% next year. Gilead Sciences Josh — Gilead (GILD) , as you can see in the chart above, is not done going up. This name has been on the list for most of the year so far. At the market lows this spring, it never violated its upward-sloping 200-day moving average — didn't even pay it a visit. And just for fun, below is the "forever" chart back to the company's IPO. I am a believer that price has memory, but I'm not sure there are still a lot of shareholders hanging around here from the last time it traded near the $120 level a decade ago. That said, I wouldn't be surprised to see a battle at that old high as new shareholders buy from sellers who are just thrilled to be getting out break-even. That's what makes a market. Sean — Gilead Sciences (GILD) has been on a run. Its experimental HIV prevention shot, lenacapavir, showed near-complete effectiveness in trials and is expected to generate $2–4 billion in peak annual sales—potentially transforming the HIV prevention market. The company has also posted solid financial results, with 2024 revenue and earnings rising due to strong performance in its HIV, liver disease, and oncology franchises. Analysts have raised price targets across the board, reflecting increased confidence in the company's pipeline and execution. GILD has a meaningful run rate of free cash flow (~$9.6B) and a growing pipeline of drugs for the future. DISCLOSURES: (None) All opinions expressed by the CNBC Pro contributors are solely their opinions and do not reflect the opinions of CNBC, NBC UNIVERSAL, their parent company or affiliates, and may have been previously disseminated by them on television, radio, internet or another medium. THE ABOVE CONTENT IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY . THIS CONTENT IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSITUTE FINANCIAL, INVESTMENT, TAX OR LEGAL ADVICE OR A RECOMMENDATION TO BUY ANY SECURITY OR OTHER FINANCIAL ASSET. THE CONTENT IS GENERAL IN NATURE AND DOES NOT REFLECT ANY INDIVIDUAL'S UNIQUE PERSONAL CIRCUMSTANCES. THE ABOVE CONTENT MIGHT NOT BE SUITABLE FOR YOUR PARTICULAR CIRCUMSTANCES. BEFORE MAKING ANY FINANCIAL DECISIONS, YOU SHOULD STRONGLY CONSIDER SEEKING ADVICE FROM YOUR OWN FINANCIAL OR INVESTMENT ADVISOR. INVESTING INVOLVES RISK. EXAMPLES OF ANALYSIS CONTAINED IN THIS ARTICLE ARE ONLY EXAMPLES. THE VIEWS AND OPINIONS EXPRESSED ARE THOSE OF THE CONTRIBUTORS AND DO NOT NECESSARILY REFLECT THE OFFICIAL POLICY OR POSITION OF RITHOLTZ WEALTH MANAGEMENT, LLC. JOSH BROWN IS THE CEO OF RITHOLTZ WEALTH MANAGEMENT AND MAY MAINTAIN A SECURITY POSITION IN THE SECURITIES DISCUSSED. ASSUMPTIONS MADE WITHIN THE ANALYSIS ARE NOT REFLECTIVE OF THE POSITION OF RITHOLTZ WEALTH MANAGEMENT, LLC" TO THE END OF OR OUR DISCLOSURE. Click here for the full disclaimer.

14 Of The Best Finance Podcasts All Investors Should Listen To
14 Of The Best Finance Podcasts All Investors Should Listen To

Forbes

time3 days ago

  • Forbes

14 Of The Best Finance Podcasts All Investors Should Listen To

Every type of investor and finance professional can find a finance podcast from this list. Whether you're just beginning your investing journey or a seasoned investment professional, there's always more to learn whether you're seeking out market commentary, lessons from economic history or alternative ideas from financial experts. Besides articles from established financial publications like Forbes or the Wall Street Journal, one of the best ways to access financial news and strategies are podcasts, especially because of their convenience and accessibility. With thousands of finance podcasts across the podcast platforms, it can be daunting to find the right ones for you, based on your experience or preference. This article will make it easy to cut through the noise with options for every stage of the investor journey and format. You'll learn of podcasts providing interviews with finance experts, witty commentary and deep dives into the best investors from history, all delivering expertise which will help you become a better investor or financial professional. These leading finance podcasts will deliver market analysis, personal financial guidance, and investment lessons from the past, making your commute or excel work fly by. Each of these podcasts are under one hour and provide unique value, helping to round out your financial knowledge. The Compound and Friends, hosted by Josh Brown and Michael Batnick of Ritholtz Wealth Management, delivers a blend of insider financial insight from industry professionals with humor on a weekly basis. Their episodes include guest appearances from famous investors, finance journalists and economists, sharing expertise and riffing with the hosts. You can expect timely commentary on market moves and Fed actions, as well as current events and their implications, all interspersed with jokes. The access to finance experts this podcast provides as well as the host's banter delivers the right mix of investment guidance and Wall Street friendship simulation. Who should listen to this? Beginning and as seasoned investors seeking great (and funny) finance takes. Where can you listen to this podcast? Available on all major podcast platforms. Streetwise, hosted by Jack Hough, offers the latest in finance news from Barron's in under thirty minutes each week. Each episode provides must-know updates on the market's latest news. Streetwise often includes interviews with market makers including Cathie Wood and Abby Joseph Cohen. Who should listen to this? On-the-go investors and finance professionals who want brief, credible market commentary. Where can you listen to this podcast? Available on all major podcast platforms. Animal Spirits, hosted by Michael Batnick and Ben Carlson, delivers the latest market takes with personal finance stories and relatable listener question and answer sessions. This duo have discussed the gauntlet from index fund portfolio management to spending psychology. Guests on the podcast have included finance experts like Morgan Housel. Animal Spirits releases episodes twice a week and delivers an easy outlet to stay on top of the big market themes each week. Who should listen to this? Investors seeking accessible financial takes and wisdom. Where can you listen to this podcast? Available on all major podcast platforms. Money Stuff is the audio companion to Bloomberg Opinion's popular Money Stuff column, hosted by the column's author Matt Levine and Bloomberg News reporter, Katie Greifeld. Levine and Greifeld explore the world of Wall Street and cryptocurrency with humorous but expert commentary, often granularly digging into niche finance stories with an eye for the personalities driving them. Like the column (which you should also subscribe to), you'll come away from each episode informed about the world of high finance, complex financial instruments, charlatans and more. Who should listen to this? Finance professionals seeking funny, in-depth insights on the most interesting stories in finance. Where can you listen to this podcast? Available on all major podcast platforms. Odd Lots, hosted by Joe Weisenthal and Tracy Alloway of Bloomberg, investigates the fascinating and often technical world of global finance. The hosts will often have on experts like Zoltan Pozcar to explore in-depth topics like global liquidity inflows, and even once had on Sam Bankman-Fried (before his fall from grace and fraud sentencing) to discuss the convoluted world of decentralized finance. Odd Lots is a fantastic source for experienced investors and finance professionals to explore the strange world of finance and how it truly works. Who should listen to this? Investors seeking substantive but humorous commentary on policy, macro economics, and global markets. Where can you listen to this podcast? Available on all major podcast platforms. Earn & Invest, hosted by Dr. Jordan Grumet, offers interviews with leading FIRE (Financial Independence, Retire Early) leaders, authors and entrepreneurs all seeking effective retirement strategies. The show provides a mix of personal storytelling from Dr. Grumet with actionable takeaways for listeners. One of Earn & Invest's best episodes featured J.L. Collins sharing the power of index investing in a very convincing way for laypeople investors. Who should listen to this? Investors seeking wealth-building tips and advice. Where can you listen to this podcast? Available on all major podcast platforms. Masters in Business, hosted by Barry Ritholtz, delivers expert interviews with industry celebrities like Ray Dalio and Bill Gross. Ritholtz asks engaging questions, fueled by his own extensive experience, helping the listener to discover actionable insights for their own portfolio or career. If you're looking for a podcast chock-full of real-world investing lessons, this is a must-subscribe. Who should listen to this? Intermediate to expert investors and finance professionals seeking insights. Where can you listen to this podcast? Available on all major podcast platforms. On the Brink, hosted by Nic Carter and Matt Walsh of Castle Island Ventures, dives deep into the sometimes inscrutable world of cryptocurrency with a special eye on crypto policy, venture capital and infrastructure. This is not a podcast dedicated to pushing a particular altcoin or preaching to true believers, but rather is focused on sober, thoughtful analysis of the future of cryptocurrency. With expert guests like SEC Commissioner Hester Peirce and Chris Dixon of a16z, you're certain to expand your crypto horizons with every listen. Who should listen to this? Cryptocurrency investors seeking substantive analysis from seasoned professionals. Where can you listen to this podcast? Available on all major podcast platforms. Sound Retirement Planning, hosted by retirement planner Jason Parker, provides the strategies and data-back insights to plan for and manage a successful retirement. Parker delivers step-by-step case studies and explanations, making complex strategies accessible to the layperson. This podcast goes multiple levels deeper on the topic of retirement planning than the average guidance you've heard, fueled sometimes by guests like Wade Pfau to share risk mitigation and planning advice. Who should listen to this? Investors planning for retirement or retirees seeking financial security. Where can you listen to this podcast? Available on all major podcast platforms. Invest Like the Best, hosted by Patrick O'Shaughnessy, showcases interviews with leading investors like Josh Wolfe, Annie Duke and Brent Beshore. Each episode is a masterclass in investing frameworks, strategies and mental models all intended to help you improve your investing chops. Invest Like the Best is a dependable finance podcast, sure to help you along in your investing journey whether you're a beginner or professional. Who should listen to this? Investors and industry professionals interested in learning from finance and business leaders. Where can you listen to this podcast? Available on all major podcast platforms. Your Money Briefing, produced by the Wall Street Journal and hosted by J.R. Whalen, is a podcast which delivers brief updates on everything from personal finance, tax strategy and market news. This podcast incorporates interviews with WSJ reporters like Greg Iacurci to deliver the very latest in market commentary. While brief, these succinct episodes will give you the necessary debrief to stay informed and up to date with market news. Who should listen to this? Everyday listeners seeking market news and updates. Where can you listen to this podcast? Available on all major podcast platforms. The Long View, hosted by Christine Benz, Dan Lefkovitz and Amy C. Arnott, shares interviews with top leaders from the investment world from retirement planners, fund managers and financial researchers. Notable guests on the podcast include leading investors like Burton Malkiel and Bill Bernstein. If you're seeking out guidance on evidence-based investing, The Long View is a must-listen. Who should listen to this? Long-term investors and retirement industry professionals who value data-driven and actionable advice. Where can you listen to this podcast? Available on all major podcast platforms. This podcast, hosted by Stig Brodersen, Preston Pysh, William Green, Clay Finck and Kyle Grieve, investigates the financial strategies and insights from the world's best investors including Warren Buffett, Charlie Munger and Ray Dalio, as well as other historical and contemporary investors. The podcast also digs deep into current market events, investment ideas, and the smart moves of other billionaires and successful companies. Notable guests on the podcast also include Chamath Palihapitiya of the All-In Podcast fame. Who should listen to this? Investors seeking financial insights from billionaires and successful businesspeople. Where can you listen to this podcast? Available on all major podcast platforms. Wall Street Lunch, hosted by Seeking Alpha's news team, delivers market commentary based on the day's top financial headlines and market moves. This podcast includes guests including industry experts like Seeking Alpha contributor Daniel Jones delivering fast reports on the day's market news, company updates and macro news. Wall Street Lunch episodes are brief, clocking in under 10 minutes, as the name suggests, making it ideal for busy finance professionals seeking to stay on top of market news without excess time expenditure. Who should listen to this? Investors seeking a rapid response to the day's biggest market stories in easily digestible increments. Where can you listen to this podcast? Available on all major podcast platforms. Bottom Line Every type of investor and finance professional can find a finance podcast from this list to satisfy their need for personal finance guidance, market commentary, witty takes on niche finance stories or insights from leading experts. As you've learned the finance podcast world is dense with options, delivering their own unique spin to what many would incorrectly assume is a dull subject. Whether you're looking for crypto commentary, actionable strategies for your retirement, or a deep dive into a 20th century financial wizard, this list has an option for you. If you're looking for even more options, make sure to check out the best investing podcasts.

Josh Brown says Tesla investor base doesn't care about Musk-Trump feud: 'I wouldn't bet against it'
Josh Brown says Tesla investor base doesn't care about Musk-Trump feud: 'I wouldn't bet against it'

CNBC

time4 days ago

  • CNBC

Josh Brown says Tesla investor base doesn't care about Musk-Trump feud: 'I wouldn't bet against it'

Ritholtz Wealth Management CEO Josh Brown said Tesla investors will look past the online feud between Elon Musk and President Donald Trump that led to a sell-off on Thursday. Musk, the CEO of Tesla and a key supporter of Trump during his election, exchanged barbs with the president online on Thursday — a shocking turn given their previous allegiance. Shares of the electric vehicle maker tumbled more than 14% on Thursday, but gained more than 5% in midday trading on Friday. "The drama on Twitter is hilarious. Of course, everyone's having a great time," Brown said on CNBC's "Halftime Report," using the former name for social media platform X. "But I think the real story here is the investor base in Tesla literally doesn't care about anything." TSLA 5D mountain Tesla, 5-day Brown pointed out that Tesla is losing market share in most key areas. However, he said investors have decided to think of the company as a robot and automation name with some artificial intelligence work rather than an electric vehicle maker. Investors think "the car sales are only important insofar as they get us to the robotaxi, which is the next trillion-dollar idea," Brown said. "I don't believe that, but that's what the market believes." Brown called the name a "nothing-matters stock," noting that it trades at 120-times earnings. He said investors may use Thursday's sell-off as a chance to buy on a dip. Shares are now down more than 25% in 2025. "It's just incredible how faithful this shareholder base is," Brown said. "I wouldn't bet against it." All opinions expressed by the CNBC Pro contributors are solely their opinions and do not reflect the opinions of CNBC, NBC UNIVERSAL, their parent company or affiliates, and may have been previously disseminated by them on television, radio, internet or another medium. THE ABOVE CONTENT IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY . THIS CONTENT IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSITUTE FINANCIAL, INVESTMENT, TAX OR LEGAL ADVICE OR A RECOMMENDATION TO BUY ANY SECURITY OR OTHER FINANCIAL ASSET. THE CONTENT IS GENERAL IN NATURE AND DOES NOT REFLECT ANY INDIVIDUAL'S UNIQUE PERSONAL CIRCUMSTANCES. THE ABOVE CONTENT MIGHT NOT BE SUITABLE FOR YOUR PARTICULAR CIRCUMSTANCES. BEFORE MAKING ANY FINANCIAL DECISIONS, YOU SHOULD STRONGLY CONSIDER SEEKING ADVICE FROM YOUR OWN FINANCIAL OR INVESTMENT ADVISOR. INVESTING INVOLVES RISK. EXAMPLES OF ANALYSIS CONTAINED IN THIS ARTICLE ARE ONLY EXAMPLES. THE VIEWS AND OPINIONS EXPRESSED ARE THOSE OF THE CONTRIBUTORS AND DO NOT NECESSARILY REFLECT THE OFFICIAL POLICY OR POSITION OF RITHOLTZ WEALTH MANAGEMENT, LLC. JOSH BROWN IS THE CEO OF RITHOLTZ WEALTH MANAGEMENT AND MAY MAINTAIN A SECURITY POSITION IN THE SECURITIES DISCUSSED. ASSUMPTIONS MADE WITHIN THE ANALYSIS ARE NOT REFLECTIVE OF THE POSITION OF RITHOLTZ WEALTH MANAGEMENT, LLC" TO THE END OF OR OUR DISCLOSURE. Click here for the full disclaimer.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store